Analysis of the key themes driving M&A activity reveals that artificial intelligence accounted for 7 medical devices deals announced in Q3 2022, worth a total value of $3.7m, according to GlobalData’s whitepaper on Artificial Intelligence in Medical Devices – M&A Deal Activity in Q3 2022. The $2.9m acquisition of Pilloxa by iZafe Group was the industry’s largest disclosed deal.

In value terms, artificial intelligence-related deal activity decreased by 82% in Q3 2022 compared with the previous quarter’s total of $20m and fell by 98% as compared to Q3 2021. Related deal volume increased by 133% in Q3 2022 versus the previous quarter and was 22% lower than in Q3 2021.

GlobalData
Report-cover

White Papers Who’s acquiring who? Artificial Intelligence in Medical Devices – M&A Deal Activity in Q3 2022

Get the whitepaper

Related Company Profiles

View all






                     
   







Top 5 M&A deals related to artificial intelligence in the medical devices industry since 2021






Target
Acquirer
Deal Value ($M)
Deal Date




Preventice
Boston Scientific
$1,225M
Jan-21




Decipher Biosciences
Veracyte
$600M
Feb-21




Modern Fertility
Roman Health Ventures
$225M
May-21




Inventive Healthcare Solutions; Virusight Diagnostic

$111M
Aug-21




Vicarious Surgical

$102M
Apr-21






  Source: GlobalData Deals Database 






        


                                        

                            GlobalData
                                    
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.


GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.


This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Acquisition, Asset transactions and Mergers.